rs34973695

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003126.4(SPTA1):​c.4453C>T​(p.Leu1485Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0233 in 1,613,524 control chromosomes in the GnomAD database, including 524 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.018 ( 39 hom., cov: 32)
Exomes 𝑓: 0.024 ( 485 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

5
9
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 4.61

Publications

8 publications found
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]
SPTA1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • elliptocytosis 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • pyropoikilocytosis, hereditary
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009739518).
BP6
Variant 1-158642966-G-A is Benign according to our data. Variant chr1-158642966-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 258938.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0176 (2677/152166) while in subpopulation SAS AF = 0.0281 (135/4806). AF 95% confidence interval is 0.0258. There are 39 homozygotes in GnomAd4. There are 1271 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003126.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTA1
NM_003126.4
MANE Select
c.4453C>Tp.Leu1485Phe
missense
Exon 32 of 52NP_003117.2P02549-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTA1
ENST00000643759.2
MANE Select
c.4453C>Tp.Leu1485Phe
missense
Exon 32 of 52ENSP00000495214.1P02549-1

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2674
AN:
152046
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00435
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0145
Gnomad ASJ
AF:
0.0406
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.0274
Gnomad FIN
AF:
0.0126
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.0268
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0198
AC:
4933
AN:
248812
AF XY:
0.0212
show subpopulations
Gnomad AFR exome
AF:
0.00484
Gnomad AMR exome
AF:
0.0130
Gnomad ASJ exome
AF:
0.0331
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.0127
Gnomad NFE exome
AF:
0.0252
Gnomad OTH exome
AF:
0.0204
GnomAD4 exome
AF:
0.0239
AC:
34963
AN:
1461358
Hom.:
485
Cov.:
33
AF XY:
0.0243
AC XY:
17630
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.00290
AC:
97
AN:
33452
American (AMR)
AF:
0.0142
AC:
634
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.0340
AC:
887
AN:
26122
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39686
South Asian (SAS)
AF:
0.0280
AC:
2411
AN:
86244
European-Finnish (FIN)
AF:
0.0128
AC:
684
AN:
53392
Middle Eastern (MID)
AF:
0.00938
AC:
54
AN:
5756
European-Non Finnish (NFE)
AF:
0.0260
AC:
28870
AN:
1111696
Other (OTH)
AF:
0.0219
AC:
1322
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2172
4344
6517
8689
10861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1086
2172
3258
4344
5430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0176
AC:
2677
AN:
152166
Hom.:
39
Cov.:
32
AF XY:
0.0171
AC XY:
1271
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.00433
AC:
180
AN:
41548
American (AMR)
AF:
0.0145
AC:
221
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0406
AC:
141
AN:
3472
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5176
South Asian (SAS)
AF:
0.0281
AC:
135
AN:
4806
European-Finnish (FIN)
AF:
0.0126
AC:
133
AN:
10580
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0268
AC:
1821
AN:
67990
Other (OTH)
AF:
0.0156
AC:
33
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
136
271
407
542
678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0238
Hom.:
158
Bravo
AF:
0.0173
TwinsUK
AF:
0.0235
AC:
87
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.00476
AC:
19
ESP6500EA
AF:
0.0247
AC:
206
ExAC
AF:
0.0194
AC:
2347
Asia WGS
AF:
0.0130
AC:
48
AN:
3478
EpiCase
AF:
0.0266
EpiControl
AF:
0.0272

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
1
Elliptocytosis 2 (1)
-
1
-
Hereditary spherocytosis type 3 (1)
-
-
1
not specified (1)
-
1
-
Pyropoikilocytosis, hereditary (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D
Eigen
Pathogenic
0.81
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.0097
T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
4.6
PrimateAI
Uncertain
0.48
T
PROVEAN
Uncertain
-3.5
D
REVEL
Uncertain
0.53
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.42
MPC
0.23
ClinPred
0.053
T
GERP RS
5.2
Varity_R
0.59
gMVP
0.30
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34973695; hg19: chr1-158612756; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.